Obesity is a complex disease caused by increased calorie intake and reduced physical activity. Most people have tried willpower and lifestyle changes to manage this condition with little success. FDA-approved medications like Semaglutide, also known by the brand names Ozempic and Wegovy can be effective for weight loss for people who are overweight or obese. Semaglutide is a once-a-week injectable peptide that mimics the GLP-1 hormone released in the gut in response to eating. This medication helps the body to produce more insulin which lowers blood sugar and decreases appetite making people feel full. Significant weight loss has been observed when Semaglutide is combined with a healthy diet and exercise. Weight loss can improve weight related conditions like high cholesterol, high blood pressure, Type 2 Diabetes, pre-diabetes, non-alcoholic fatty liver, and joint pain. In 2023 the SELECT research trial found that overweight or obese adults who took Semaglutide for more than three years had a 20% lower risk of heart attack, stroke, or death from heart disease. Research also found that adults treated with Semaglutide for up to 15 months were able to maintain their weight loss for up to four years. Case study: 38-year-old female was interested in losing weight to improve her health. She had tried all the known weight loss programs in the past but was unsuccessful. She did Semaglutide for nine months at PRP Regeneration Specialists and lost 43.44 pounds. She states Semaglutide “rewires how you think about food and drink”. To learn more: PRPregen.com.
Article by Wendy Wiggs APRN-C Founder & Owner PRP Regeneration Specialists
Originally published in Gainesville City Lifestyle